Physician profile
Ivan Wong
NPI 1023170073
$5,773.19
in general payments reported to CMS, 2019-2025
16 companies · $1,138 in 2025
The $1,138 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,115 · 2020: $172 · 2021: $261 · 2022: $744 · 2023: $1,337 · 2024: $1,007 · 2025: $1,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,974 · Consulting Fee: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,974.33 |
| Consulting Fee | $507.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,888.18 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,000.77 | 2019-2025 | Total30, Precision 1, Precision7 |
| Bausch & Lomb Americas INC. | $726.31 | 2022-2025 | Infuse, Biotrue, Miebo |
| Coopervision INC. | $436.19 | 2019-2025 | Myday Contact Lens, Paragon Crt, Clariti Contact Lens |
| Abb Con-Cise Optical Group LLC | $366.11 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Biotissue Holdings INC. | $314.18 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $288.72 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $200.46 | 2024 | Xdemvy |
| Visioneering Technologies, INC. | $142.80 | 2019-2020 | |
| Philips North America LLC | $124.75 | 2019 | |
| Abbvie INC. | $119.79 | 2022 | |
| Optos, INC. | $70.83 | 2022 | |
| Alcon Research LLC | $27.37 | 2019 | |
| Oyster Point Pharma, INC. | $24.57 | 2024 | Tyrvaya |
| Harrow Eye, LLC | $22.76 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.